PureTech Health plc (OTCMKTS:PTCHF) Short Interest Update

PureTech Health plc (OTCMKTS:PTCHF) saw a large increase in short interest in November. As of November 15th, there was short interest totalling 54,000 shares, an increase of 730.8% from the October 31st total of 6,500 shares. Based on an average daily volume of 25,200 shares, the short-interest ratio is presently 2.1 days.

PureTech Health Stock Down 3.8 %

Shares of PureTech Health stock traded down $0.08 during trading on Wednesday, hitting $2.02. 5,000 shares of the stock were exchanged, compared to its average volume of 32,563. PureTech Health has a 1-year low of $1.69 and a 1-year high of $3.00. The company has a fifty day moving average price of $1.97 and a 200-day moving average price of $2.23.

PureTech Health Company Profile

PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies.